APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tourette Syndrome Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tourette Syndrome Drug Market Analysis and Forecast 2026-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchTourette Syndrome Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Tourette Syndrome Drug Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Tourette Syndrome Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tourette Syndrome Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Tourette Syndrome Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Tourette Syndrome Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tourette Syndrome Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tourette Syndrome Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tourette Syndrome Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tourette Syndrome Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Tourette Syndrome Drug include Teva Pharmaceutical Industries Ltd, Therapix Biosciences Ltd, Synchroneuron Inc, Reviva Pharmaceuticals Inc, Psyadon Pharmaceuticals Inc, Neurocrine Biosciences Inc, Catalyst Pharmaceuticals Inc and Abide Therapeutics Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tourette Syndrome Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tourette Syndrome Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Tourette Syndrome Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tourette Syndrome Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tourette Syndrome Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tourette Syndrome Drug sales, projected growth trends, production technology, application and end-user industry.

Tourette Syndrome Drug Segment by Company

Teva Pharmaceutical Industries Ltd

Therapix Biosciences Ltd

Synchroneuron Inc

Reviva Pharmaceuticals Inc

Psyadon Pharmaceuticals Inc

Neurocrine Biosciences Inc

Catalyst Pharmaceuticals Inc

Abide Therapeutics Inc

Tourette Syndrome Drug Segment by Type

Ecopipam Hydrochloride

Dutetrabenazine ER

CPP-115

AZD-5213

Others

Tourette Syndrome Drug Segment by Application

Clinic

Hospital

Research Center

Others

Tourette Syndrome Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tourette Syndrome Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tourette Syndrome Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tourette Syndrome Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tourette Syndrome Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tourette Syndrome Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tourette Syndrome Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tourette Syndrome Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ecopipam Hydrochloride Major Manufacturers Table 3. Dutetrabenazine ER Major Manufacturers Table 4. CPP-115 Major Manufacturers Table 5. AZD-5213 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Tourette Syndrome Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Clinic Major Manufacturers Table 9. Hospital Major Manufacturers Table 10. Research Center Major Manufacturers Table 11. Others Major Manufacturers Table 12. Tourette Syndrome Drug Industry Trends Table 13. Tourette Syndrome Drug Industry Drivers Table 14. Tourette Syndrome Drug Industry Opportunities and Challenges Table 15. Tourette Syndrome Drug Industry Restraints Table 16. Global Tourette Syndrome Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Tourette Syndrome Drug Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Tourette Syndrome Drug Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Tourette Syndrome Drug Revenue Market Share by Region (2021-2026) Table 20. Global Tourette Syndrome Drug Revenue Market Share by Region (2027-2032) Table 21. Global Tourette Syndrome Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Tourette Syndrome Drug Sales by Region (2021-2026) & (k units) Table 23. Global Tourette Syndrome Drug Sales by Region (2027-2032) & (k units) Table 24. Global Tourette Syndrome Drug Sales Market Share by Region (2021-2026) Table 25. Global Tourette Syndrome Drug Sales Market Share by Region (2027-2032) Table 26. Global Tourette Syndrome Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Tourette Syndrome Drug Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Tourette Syndrome Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Tourette Syndrome Drug Sales Market Share by Manufacturers (2021-2026) Table 30. Global Tourette Syndrome Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Tourette Syndrome Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Tourette Syndrome Drug Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Tourette Syndrome Drug Manufacturers, Product Type & Application Table 34. Global Tourette Syndrome Drug Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Tourette Syndrome Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Tourette Syndrome Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Tourette Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Tourette Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Tourette Syndrome Drug Revenue Market Share by Type (2021-2026) Table 41. Global Tourette Syndrome Drug Revenue Market Share by Type (2027-2032) Table 42. Global Tourette Syndrome Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 44. Global Tourette Syndrome Drug Sales by Type (2027-2032) & (k units) Table 45. Global Tourette Syndrome Drug Sales Market Share by Type (2021-2026) Table 46. Global Tourette Syndrome Drug Sales Market Share by Type (2027-2032) Table 47. Global Tourette Syndrome Drug Price by Type (2021-2026) & (US$/unit) Table 48. Global Tourette Syndrome Drug Price by Type (2027-2032) & (US$/unit) Table 49. Global Tourette Syndrome Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Tourette Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Tourette Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Tourette Syndrome Drug Revenue Market Share by Application (2021-2026) Table 53. Global Tourette Syndrome Drug Revenue Market Share by Application (2027-2032) Table 54. Global Tourette Syndrome Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 56. Global Tourette Syndrome Drug Sales by Application (2027-2032) & (k units) Table 57. Global Tourette Syndrome Drug Sales Market Share by Application (2021-2026) Table 58. Global Tourette Syndrome Drug Sales Market Share by Application (2027-2032) Table 59. Global Tourette Syndrome Drug Price by Application (2021-2026) & (US$/unit) Table 60. Global Tourette Syndrome Drug Price by Application (2027-2032) & (US$/unit) Table 61. Teva Pharmaceutical Industries Ltd Company Information Table 62. Teva Pharmaceutical Industries Ltd Business Overview Table 63. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Portfolio Table 65. Teva Pharmaceutical Industries Ltd Recent Development Table 66. Therapix Biosciences Ltd Company Information Table 67. Therapix Biosciences Ltd Business Overview Table 68. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Therapix Biosciences Ltd Tourette Syndrome Drug Product Portfolio Table 70. Therapix Biosciences Ltd Recent Development Table 71. Synchroneuron Inc Company Information Table 72. Synchroneuron Inc Business Overview Table 73. Synchroneuron Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Synchroneuron Inc Tourette Syndrome Drug Product Portfolio Table 75. Synchroneuron Inc Recent Development Table 76. Reviva Pharmaceuticals Inc Company Information Table 77. Reviva Pharmaceuticals Inc Business Overview Table 78. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio Table 80. Reviva Pharmaceuticals Inc Recent Development Table 81. Psyadon Pharmaceuticals Inc Company Information Table 82. Psyadon Pharmaceuticals Inc Business Overview Table 83. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio Table 85. Psyadon Pharmaceuticals Inc Recent Development Table 86. Neurocrine Biosciences Inc Company Information Table 87. Neurocrine Biosciences Inc Business Overview Table 88. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Neurocrine Biosciences Inc Tourette Syndrome Drug Product Portfolio Table 90. Neurocrine Biosciences Inc Recent Development Table 91. Catalyst Pharmaceuticals Inc Company Information Table 92. Catalyst Pharmaceuticals Inc Business Overview Table 93. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio Table 95. Catalyst Pharmaceuticals Inc Recent Development Table 96. Abide Therapeutics Inc Company Information Table 97. Abide Therapeutics Inc Business Overview Table 98. Abide Therapeutics Inc Tourette Syndrome Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Abide Therapeutics Inc Tourette Syndrome Drug Product Portfolio Table 100. Abide Therapeutics Inc Recent Development Table 101. North America Tourette Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Tourette Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 104. North America Tourette Syndrome Drug Sales by Type (2027-2032) & (k units) Table 105. North America Tourette Syndrome Drug Sales Price by Type (2021-2026) & (US$/unit) Table 106. North America Tourette Syndrome Drug Sales Price by Type (2027-2032) & (US$/unit) Table 107. North America Tourette Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Tourette Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 110. North America Tourette Syndrome Drug Sales by Application (2027-2032) & (k units) Table 111. North America Tourette Syndrome Drug Sales Price by Application (2021-2026) & (US$/unit) Table 112. North America Tourette Syndrome Drug Sales Price by Application (2027-2032) & (US$/unit) Table 113. North America Tourette Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Tourette Syndrome Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Tourette Syndrome Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Tourette Syndrome Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 117. North America Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 118. North America Tourette Syndrome Drug Sales by Country (2027-2032) & (k units) Table 119. North America Tourette Syndrome Drug Sales Price by Country (2021-2026) & (US$/unit) Table 120. North America Tourette Syndrome Drug Sales Price by Country (2027-2032) & (US$/unit) Table 121. United States Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 122. Canada Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 123. Mexico Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 124. Europe Tourette Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Tourette Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 127. Europe Tourette Syndrome Drug Sales by Type (2027-2032) & (k units) Table 128. Europe Tourette Syndrome Drug Sales Price by Type (2021-2026) & (US$/unit) Table 129. Europe Tourette Syndrome Drug Sales Price by Type (2027-2032) & (US$/unit) Table 130. Europe Tourette Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Tourette Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 133. Europe Tourette Syndrome Drug Sales by Application (2027-2032) & (k units) Table 134. Europe Tourette Syndrome Drug Sales Price by Application (2021-2026) & (US$/unit) Table 135. Europe Tourette Syndrome Drug Sales Price by Application (2027-2032) & (US$/unit) Table 136. Europe Tourette Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Tourette Syndrome Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Tourette Syndrome Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Tourette Syndrome Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 140. Europe Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 141. Europe Tourette Syndrome Drug Sales by Country (2027-2032) & (k units) Table 142. Europe Tourette Syndrome Drug Sales Price by Country (2021-2026) & (US$/unit) Table 143. Europe Tourette Syndrome Drug Sales Price by Country (2027-2032) & (US$/unit) Table 144. Germany Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 145. France Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 146. U.K. Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 147. Italy Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 148. Russia Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 149. Spain Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 151. Switzerland Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 152. Sweden Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 153. Poland Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 154. China Tourette Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 155. China Tourette Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 156. China Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 157. China Tourette Syndrome Drug Sales by Type (2027-2032) & (k units) Table 158. China Tourette Syndrome Drug Sales Price by Type (2021-2026) & (US$/unit) Table 159. China Tourette Syndrome Drug Sales Price by Type (2027-2032) & (US$/unit) Table 160. China Tourette Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 161. China Tourette Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 162. China Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 163. China Tourette Syndrome Drug Sales by Application (2027-2032) & (k units) Table 164. China Tourette Syndrome Drug Sales Price by Application (2021-2026) & (US$/unit) Table 165. China Tourette Syndrome Drug Sales Price by Application (2027-2032) & (US$/unit) Table 166. Asia Tourette Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Tourette Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 169. Asia Tourette Syndrome Drug Sales by Type (2027-2032) & (k units) Table 170. Asia Tourette Syndrome Drug Sales Price by Type (2021-2026) & (US$/unit) Table 171. Asia Tourette Syndrome Drug Sales Price by Type (2027-2032) & (US$/unit) Table 172. Asia Tourette Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Tourette Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 175. Asia Tourette Syndrome Drug Sales by Application (2027-2032) & (k units) Table 176. Asia Tourette Syndrome Drug Sales Price by Application (2021-2026) & (US$/unit) Table 177. Asia Tourette Syndrome Drug Sales Price by Application (2027-2032) & (US$/unit) Table 178. Asia Tourette Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Tourette Syndrome Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Tourette Syndrome Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Tourette Syndrome Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 182. Asia Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 183. Asia Tourette Syndrome Drug Sales by Country (2027-2032) & (k units) Table 184. Asia Tourette Syndrome Drug Sales Price by Country (2021-2026) & (US$/unit) Table 185. Asia Tourette Syndrome Drug Sales Price by Country (2027-2032) & (US$/unit) Table 186. Japan Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 187. South Korea Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 188. India Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 189. Australia Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 190. Taiwan Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Tourette Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Tourette Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Tourette Syndrome Drug Sales by Type (2021-2026) & (k units) Table 195. SAMEA Tourette Syndrome Drug Sales by Type (2027-2032) & (k units) Table 196. SAMEA Tourette Syndrome Drug Sales Price by Type (2021-2026) & (US$/unit) Table 197. SAMEA Tourette Syndrome Drug Sales Price by Type (2027-2032) & (US$/unit) Table 198. SAMEA Tourette Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Tourette Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Tourette Syndrome Drug Sales by Application (2021-2026) & (k units) Table 201. SAMEA Tourette Syndrome Drug Sales by Application (2027-2032) & (k units) Table 202. SAMEA Tourette Syndrome Drug Sales Price by Application (2021-2026) & (US$/unit) Table 203. SAMEA Tourette Syndrome Drug Sales Price by Application (2027-2032) & (US$/unit) Table 204. SAMEA Tourette Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Tourette Syndrome Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Tourette Syndrome Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Tourette Syndrome Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 208. SAMEA Tourette Syndrome Drug Sales by Country (2021-2026) & (k units) Table 209. SAMEA Tourette Syndrome Drug Sales by Country (2027-2032) & (k units) Table 210. SAMEA Tourette Syndrome Drug Sales Price by Country (2021-2026) & (US$/unit) Table 211. SAMEA Tourette Syndrome Drug Sales Price by Country (2027-2032) & (US$/unit) Table 212. Brazil Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 213. Argentina Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 214. Chile Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 215. Colombia Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 216. Peru Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 218. Israel Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 219. UAE Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 220. Turkey Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 221. Iran Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 222. Egypt Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Tourette Syndrome Drug Distributors List Table 226. Tourette Syndrome Drug Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Tourette Syndrome Drug Image Figure 2. Global Tourette Syndrome Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tourette Syndrome Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ecopipam Hydrochloride Image Figure 5. Dutetrabenazine ER Image Figure 6. CPP-115 Image Figure 7. AZD-5213 Image Figure 8. Others Image Figure 9. Global Tourette Syndrome Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Tourette Syndrome Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Clinic Image Figure 12. Hospital Image Figure 13. Research Center Image Figure 14. Others Image Figure 15. Global Tourette Syndrome Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Tourette Syndrome Drug Revenue (2021-2032) & (US$ Million) Figure 17. Global Tourette Syndrome Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Tourette Syndrome Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Tourette Syndrome Drug Revenue Market Share by Region (2021-2032) Figure 20. Global Tourette Syndrome Drug Sales (2021-2032) & (k units) Figure 21. Global Tourette Syndrome Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Tourette Syndrome Drug Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Tourette Syndrome Drug Sales YoY (2021-2032) & (k units) Figure 24. Europe Tourette Syndrome Drug Sales YoY (2021-2032) & (k units) Figure 25. China Tourette Syndrome Drug Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Tourette Syndrome Drug Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Tourette Syndrome Drug Sales YoY (2021-2032) & (k units) Figure 28. Global Tourette Syndrome Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Tourette Syndrome Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Tourette Syndrome Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Tourette Syndrome Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Tourette Syndrome Drug Revenue Market Share by Type (2021-2032) Figure 34. Global Tourette Syndrome Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Tourette Syndrome Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Tourette Syndrome Drug Sales Market Share by Type (2021-2032) Figure 37. Global Tourette Syndrome Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Tourette Syndrome Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Tourette Syndrome Drug Revenue Market Share by Application (2021-2032) Figure 40. Global Tourette Syndrome Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Tourette Syndrome Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Tourette Syndrome Drug Sales Market Share by Application (2021-2032) Figure 43. North America Tourette Syndrome Drug Revenue Share by Type (2021-2032) Figure 44. North America Tourette Syndrome Drug Sales Share by Type (2021-2032) Figure 45. North America Tourette Syndrome Drug Revenue Share by Application (2021-2032) Figure 46. North America Tourette Syndrome Drug Sales Share by Application (2021-2032) Figure 47. North America Tourette Syndrome Drug Revenue Share by Country (2021-2032) Figure 48. North America Tourette Syndrome Drug Sales Share by Country (2021-2032) Figure 49. Europe Tourette Syndrome Drug Revenue Share by Type (2021-2032) Figure 50. Europe Tourette Syndrome Drug Sales Share by Type (2021-2032) Figure 51. Europe Tourette Syndrome Drug Revenue Share by Application (2021-2032) Figure 52. Europe Tourette Syndrome Drug Sales Share by Application (2021-2032) Figure 53. Europe Tourette Syndrome Drug Revenue Share by Country (2021-2032) Figure 54. Europe Tourette Syndrome Drug Sales Share by Country (2021-2032) Figure 55. China Tourette Syndrome Drug Revenue Share by Type (2021-2032) Figure 56. China Tourette Syndrome Drug Sales Share by Type (2021-2032) Figure 57. China Tourette Syndrome Drug Revenue Share by Application (2021-2032) Figure 58. China Tourette Syndrome Drug Sales Share by Application (2021-2032) Figure 59. Asia Tourette Syndrome Drug Revenue Share by Type (2021-2032) Figure 60. Asia Tourette Syndrome Drug Sales Share by Type (2021-2032) Figure 61. Asia Tourette Syndrome Drug Revenue Share by Application (2021-2032) Figure 62. Asia Tourette Syndrome Drug Sales Share by Application (2021-2032) Figure 63. Asia Tourette Syndrome Drug Revenue Share by Country (2021-2032) Figure 64. Asia Tourette Syndrome Drug Sales Share by Country (2021-2032) Figure 65. SAMEA Tourette Syndrome Drug Revenue Share by Type (2021-2032) Figure 66. SAMEA Tourette Syndrome Drug Sales Share by Type (2021-2032) Figure 67. SAMEA Tourette Syndrome Drug Revenue Share by Application (2021-2032) Figure 68. SAMEA Tourette Syndrome Drug Sales Share by Application (2021-2032) Figure 69. SAMEA Tourette Syndrome Drug Revenue Share by Country (2021-2032) Figure 70. SAMEA Tourette Syndrome Drug Sales Share by Country (2021-2032) Figure 71. Tourette Syndrome Drug Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Tourette Syndrome Drug Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Ecopipam Hydrochloride
  • Dutetrabenazine ER
  • CPP-115
  • AZD-5213
  • Others
Applications
  • Clinic
  • Hospital
  • Research Center
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Therapix Biosciences Ltd
  • Synchroneuron Inc
  • Reviva Pharmaceuticals Inc
  • Psyadon Pharmaceuticals Inc
  • Neurocrine Biosciences Inc
  • Catalyst Pharmaceuticals Inc
  • Abide Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tourette Syndrome Drug Market by Type
  3. 1.2.1 Global Tourette Syndrome Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ecopipam Hydrochloride
  5. 1.2.3 Dutetrabenazine ER
  6. 1.2.4 CPP-115
  7. 1.2.5 AZD-5213
  8. 1.2.6 Others
  9. 1.3 Tourette Syndrome Drug Market by Application
  10. 1.3.1 Global Tourette Syndrome Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Clinic
  12. 1.3.3 Hospital
  13. 1.3.4 Research Center
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Tourette Syndrome Drug Market Dynamics
  1. 2.1 Tourette Syndrome Drug Industry Trends
  2. 2.2 Tourette Syndrome Drug Industry Drivers
  3. 2.3 Tourette Syndrome Drug Industry Opportunities and Challenges
  4. 2.4 Tourette Syndrome Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tourette Syndrome Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tourette Syndrome Drug Revenue by Region
  3. 3.2.1 Global Tourette Syndrome Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tourette Syndrome Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Tourette Syndrome Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Tourette Syndrome Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tourette Syndrome Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tourette Syndrome Drug Sales by Region
  9. 3.4.1 Global Tourette Syndrome Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tourette Syndrome Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Tourette Syndrome Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Tourette Syndrome Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tourette Syndrome Drug Revenue by Manufacturers
  2. 4.1.1 Global Tourette Syndrome Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tourette Syndrome Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tourette Syndrome Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tourette Syndrome Drug Sales by Manufacturers
  6. 4.2.1 Global Tourette Syndrome Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tourette Syndrome Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tourette Syndrome Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tourette Syndrome Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tourette Syndrome Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tourette Syndrome Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tourette Syndrome Drug Manufacturers, Product Type & Application
  13. 4.7 Global Tourette Syndrome Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tourette Syndrome Drug Market CR5 and HHI
  16. 4.8.2 2025 Tourette Syndrome Drug Tier 1, Tier 2, and Tier 3
5 Tourette Syndrome Drug Market by Type
  1. 5.1 Global Tourette Syndrome Drug Revenue by Type
  2. 5.1.1 Global Tourette Syndrome Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tourette Syndrome Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tourette Syndrome Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tourette Syndrome Drug Sales by Type
  6. 5.2.1 Global Tourette Syndrome Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tourette Syndrome Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Tourette Syndrome Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tourette Syndrome Drug Price by Type
6 Tourette Syndrome Drug Market by Application
  1. 6.1 Global Tourette Syndrome Drug Revenue by Application
  2. 6.1.1 Global Tourette Syndrome Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tourette Syndrome Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tourette Syndrome Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tourette Syndrome Drug Sales by Application
  6. 6.2.1 Global Tourette Syndrome Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tourette Syndrome Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Tourette Syndrome Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tourette Syndrome Drug Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries Ltd
  2. 7.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 7.2 Therapix Biosciences Ltd
  8. 7.2.1 Therapix Biosciences Ltd Company Information
  9. 7.2.2 Therapix Biosciences Ltd Business Overview
  10. 7.2.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Therapix Biosciences Ltd Tourette Syndrome Drug Product Portfolio
  12. 7.2.5 Therapix Biosciences Ltd Recent Developments
  13. 7.3 Synchroneuron Inc
  14. 7.3.1 Synchroneuron Inc Company Information
  15. 7.3.2 Synchroneuron Inc Business Overview
  16. 7.3.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Synchroneuron Inc Tourette Syndrome Drug Product Portfolio
  18. 7.3.5 Synchroneuron Inc Recent Developments
  19. 7.4 Reviva Pharmaceuticals Inc
  20. 7.4.1 Reviva Pharmaceuticals Inc Company Information
  21. 7.4.2 Reviva Pharmaceuticals Inc Business Overview
  22. 7.4.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
  24. 7.4.5 Reviva Pharmaceuticals Inc Recent Developments
  25. 7.5 Psyadon Pharmaceuticals Inc
  26. 7.5.1 Psyadon Pharmaceuticals Inc Company Information
  27. 7.5.2 Psyadon Pharmaceuticals Inc Business Overview
  28. 7.5.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
  30. 7.5.5 Psyadon Pharmaceuticals Inc Recent Developments
  31. 7.6 Neurocrine Biosciences Inc
  32. 7.6.1 Neurocrine Biosciences Inc Company Information
  33. 7.6.2 Neurocrine Biosciences Inc Business Overview
  34. 7.6.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Product Portfolio
  36. 7.6.5 Neurocrine Biosciences Inc Recent Developments
  37. 7.7 Catalyst Pharmaceuticals Inc
  38. 7.7.1 Catalyst Pharmaceuticals Inc Company Information
  39. 7.7.2 Catalyst Pharmaceuticals Inc Business Overview
  40. 7.7.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio
  42. 7.7.5 Catalyst Pharmaceuticals Inc Recent Developments
  43. 7.8 Abide Therapeutics Inc
  44. 7.8.1 Abide Therapeutics Inc Company Information
  45. 7.8.2 Abide Therapeutics Inc Business Overview
  46. 7.8.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Abide Therapeutics Inc Tourette Syndrome Drug Product Portfolio
  48. 7.8.5 Abide Therapeutics Inc Recent Developments
8 North America
  1. 8.1 North America Tourette Syndrome Drug Market Size by Type
  2. 8.1.1 North America Tourette Syndrome Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Tourette Syndrome Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Tourette Syndrome Drug Price by Type (2021-2032)
  5. 8.2 North America Tourette Syndrome Drug Market Size by Application
  6. 8.2.1 North America Tourette Syndrome Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Tourette Syndrome Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Tourette Syndrome Drug Price by Application (2021-2032)
  9. 8.3 North America Tourette Syndrome Drug Market Size by Country
  10. 8.3.1 North America Tourette Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tourette Syndrome Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tourette Syndrome Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Tourette Syndrome Drug Market Size by Type
  2. 9.1.1 Europe Tourette Syndrome Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tourette Syndrome Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Tourette Syndrome Drug Price by Type (2021-2032)
  5. 9.2 Europe Tourette Syndrome Drug Market Size by Application
  6. 9.2.1 Europe Tourette Syndrome Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tourette Syndrome Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Tourette Syndrome Drug Price by Application (2021-2032)
  9. 9.3 Europe Tourette Syndrome Drug Market Size by Country
  10. 9.3.1 Europe Tourette Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tourette Syndrome Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tourette Syndrome Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Tourette Syndrome Drug Market Size by Type
  2. 10.1.1 China Tourette Syndrome Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Tourette Syndrome Drug Sales by Type (2021-2032)
  4. 10.1.3 China Tourette Syndrome Drug Price by Type (2021-2032)
  5. 10.2 China Tourette Syndrome Drug Market Size by Application
  6. 10.2.1 China Tourette Syndrome Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Tourette Syndrome Drug Sales by Application (2021-2032)
  8. 10.2.3 China Tourette Syndrome Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tourette Syndrome Drug Market Size by Type
  2. 11.1.1 Asia Tourette Syndrome Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tourette Syndrome Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Tourette Syndrome Drug Price by Type (2021-2032)
  5. 11.2 Asia Tourette Syndrome Drug Market Size by Application
  6. 11.2.1 Asia Tourette Syndrome Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tourette Syndrome Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Tourette Syndrome Drug Price by Application (2021-2032)
  9. 11.3 Asia Tourette Syndrome Drug Market Size by Country
  10. 11.3.1 Asia Tourette Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tourette Syndrome Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tourette Syndrome Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tourette Syndrome Drug Market Size by Type
  2. 12.1.1 SAMEA Tourette Syndrome Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tourette Syndrome Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tourette Syndrome Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Tourette Syndrome Drug Market Size by Application
  6. 12.2.1 SAMEA Tourette Syndrome Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tourette Syndrome Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tourette Syndrome Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Tourette Syndrome Drug Market Size by Country
  10. 12.3.1 SAMEA Tourette Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tourette Syndrome Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tourette Syndrome Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tourette Syndrome Drug Value Chain Analysis
  2. 13.1.1 Tourette Syndrome Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tourette Syndrome Drug Production Mode & Process
  6. 13.2 Tourette Syndrome Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tourette Syndrome Drug Distributors
  9. 13.2.3 Tourette Syndrome Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst